BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

408 related articles for article (PubMed ID: 35811332)

  • 1. Bioinformatics roadmap for therapy selection in cancer genomics.
    Jiménez-Santos MJ; García-Martín S; Fustero-Torre C; Di Domenico T; Gómez-López G; Al-Shahrour F
    Mol Oncol; 2022 Nov; 16(21):3881-3908. PubMed ID: 35811332
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bioinformatics workflows for clinical applications in precision oncology.
    Jäger N
    Semin Cancer Biol; 2022 Sep; 84():103-112. PubMed ID: 33476720
    [TBL] [Abstract][Full Text] [Related]  

  • 3. GeNeo: A Bioinformatics Toolbox for Genomics-Guided Neoepitope Prediction.
    Al Seesi S; Al-Okaily A; Shcheglova TV; Sherafat E; Alqahtani FH; Hagymasi AT; Kaur A; Srivastava PK; Măndoiu II
    J Comput Biol; 2023 Apr; 30(4):538-551. PubMed ID: 36999902
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bioinformatics for precision oncology.
    Singer J; Irmisch A; Ruscheweyh HJ; Singer F; Toussaint NC; Levesque MP; Stekhoven DJ; Beerenwinkel N
    Brief Bioinform; 2019 May; 20(3):778-788. PubMed ID: 29272324
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multi-Omics Model Applied to Cancer Genetics.
    Pettini F; Visibelli A; Cicaloni V; Iovinelli D; Spiga O
    Int J Mol Sci; 2021 May; 22(11):. PubMed ID: 34072237
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The use of PanDrugs to prioritize anticancer drug treatments in a case of T-ALL based on individual genomic data.
    Fernández-Navarro P; López-Nieva P; Piñeiro-Yañez E; Carreño-Tarragona G; Martinez-López J; Sánchez Pérez R; Aroca Á; Al-Shahrour F; Cobos-Fernández MÁ; Fernández-Piqueras J
    BMC Cancer; 2019 Oct; 19(1):1005. PubMed ID: 31655559
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Implementing next-generation sequencing for precision hematology/oncology].
    Maeda T
    Rinsho Ketsueki; 2018; 59(10):1924-1934. PubMed ID: 30305493
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Individualized network-based drug repositioning infrastructure for precision oncology in the panomics era.
    Cheng F; Hong H; Yang S; Wei Y
    Brief Bioinform; 2017 Jul; 18(4):682-697. PubMed ID: 27296652
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Software Workflows and Infrastructures for Precision Oncology.
    Osman W; Laganà A
    Adv Exp Med Biol; 2022; 1361():23-35. PubMed ID: 35230681
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Precision diagnostics: integration of tissue pathology and genomics in cancer.
    Sharma S; George P; Waddell N
    Pathology; 2021 Dec; 53(7):809-817. PubMed ID: 34635323
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Precision oncology for patients with advanced cancer: the challenges of malignant snowflakes.
    Kurzrock R; Giles FJ
    Cell Cycle; 2015; 14(14):2219-21. PubMed ID: 26030337
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Advancing clinical genomics and precision medicine with GVViZ: FAIR bioinformatics platform for variable gene-disease annotation, visualization, and expression analysis.
    Ahmed Z; Renart EG; Zeeshan S; Dong X
    Hum Genomics; 2021 Jun; 15(1):37. PubMed ID: 34174938
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bioinformatics Data Analysis of Next-Generation Sequencing Data from Heterogeneous Tumor Samples.
    Landman SR; Hwang TH
    Methods Mol Biol; 2017; 1633():185-192. PubMed ID: 28735488
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Precision Oncology Beyond Genomics: The Future Is Here-It Is Just Not Evenly Distributed.
    Pfohl U; Pflaume A; Regenbrecht M; Finkler S; Graf Adelmann Q; Reinhard C; Regenbrecht CRA; Wedeken L
    Cells; 2021 Apr; 10(4):. PubMed ID: 33920536
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Need for Multi-Omics Biomarker Signatures in Precision Medicine.
    Olivier M; Asmis R; Hawkins GA; Howard TD; Cox LA
    Int J Mol Sci; 2019 Sep; 20(19):. PubMed ID: 31561483
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Operationalizing Quality Assurance for Clinical Illumina Somatic Next-Generation Sequencing Pipelines.
    Bridgers J; Alexander K; Karsan A
    J Mol Diagn; 2024 Feb; 26(2):96-105. PubMed ID: 38086510
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IOBR: Multi-Omics Immuno-Oncology Biological Research to Decode Tumor Microenvironment and Signatures.
    Zeng D; Ye Z; Shen R; Yu G; Wu J; Xiong Y; Zhou R; Qiu W; Huang N; Sun L; Li X; Bin J; Liao Y; Shi M; Liao W
    Front Immunol; 2021; 12():687975. PubMed ID: 34276676
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genomics and bioinformatics as pillars of precision medicine in oncology.
    Canzoneri R; Lacunza E; Abba MC
    Medicina (B Aires); 2019; 79(Spec 6/1):587-592. PubMed ID: 31864231
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The challenge of intratumour heterogeneity in precision medicine.
    Seoane J; De Mattos-Arruda L
    J Intern Med; 2014 Jul; 276(1):41-51. PubMed ID: 24661605
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bringing precision oncology to cellular resolution with single-cell genomics.
    Xia Y; Gawad C
    Clin Exp Metastasis; 2022 Feb; 39(1):79-83. PubMed ID: 34807338
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.